Patent · US Active

Method and apparatus for rapid detection of SARS-CoV-2

US11320434B2 · kind B2 · utility

0Cited by
1References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 3, 2021
Grant dateMay 3, 2022
Priority date
Expiry dateJun 3, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/165
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method and apparatus for comfortably, rapidly, and inexpensively collecting a sample from one or more test subjects and analyzing it, singly or pooled with other samples, for presence of SARS-CoV-2. Saliva, nasal drainage, or other body fluids may be collected from one or more test subjects and examined by means of fluorimetry. Mass rapid screening for SARS-CoV-2 is a valuable public health tool to reduce the transmission of COVID-19 while permitting business activity to resume.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.